Challenges and Considerations on Risk-Reducing Surgery in <i>BRCA1/2</i> Patients with Advanced Breast Cancer
Cancer survivors harboring inherited pathogenic variants in the breast cancer (BC) susceptibility genes <i>BRCA1</i> or <i>BRCA2</i> are at increased risk of ovarian cancer (OC) and also of contralateral BC. For these women, risk-reducing surgery (RRS) may contribute to risk...
Main Authors: | Leonor Vasconcelos de Matos, Leonor Fernandes, Pedro Louro, Ana Plácido, Manuel Barros, Fátima Vaz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/28/1/50 |
Similar Items
-
BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01) -
Differences in Ovarian and Other Cancers Risks by Population and <i>BRCA</i> Mutation Location
by: Masayuki Sekine, et al.
Published: (2021-07-01) -
Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers – an interventional randomized controlled multicenter trial (LIBRE-1)
by: Marion Kiechle, et al.
Published: (2017-11-01) -
Non-Coding Variants in <i>BRCA1</i> and <i>BRCA2</i> Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
by: Elizabeth Santana dos Santos, et al.
Published: (2018-11-01) -
Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)
by: Fatima Zahra El Ansari, et al.
Published: (2020-08-01)